Bend Research and The Dow Chemical Company Collaborate to Develop Drug-Solubility Solutions and New Polymers

Published: Oct 04, 2012

MIDLAND, Mich. & BEND, Ore.--(BUSINESS WIRE)--Bend Research Inc., a leading independent drug-formulation development and manufacturing company and The Dow Chemical Company (NYSE:DOW), a global leader in designing, manufacturing, and supplying polymeric excipients for enabling drug-delivery systems, have formed an exclusive collaboration to provide science-based spray-dried dispersion (SDD) solutions and select enabling new polymers for poorly soluble oral drugs.

Back to news